[JAK inhibitors - a new therapeutic option for inflammatory bowel disease]
MMW Fortschr Med
.
2022 Dec;164(21-22):67-69.
doi: 10.1007/s15006-022-2176-1.
[Article in German]
Authors
Klaus R Herrlinger
1
,
Eduard F Stange
2
Affiliations
1
Innere Medizin I, Asklepios Klinik Nord, Tangstedter Landstr. 400, 22417, Hamburg, Deutschland.
2
Klinik für Innere Medizin I, Universitätsklinikum Tübingen, Otfried-Müller-Str. 10, 72076, Tübingen, Deutschland. eduard.stange@icloud.com.
PMID:
36510076
DOI:
10.1007/s15006-022-2176-1
No abstract available
Publication types
Review
MeSH terms
Humans
Inflammatory Bowel Diseases* / drug therapy
Janus Kinase Inhibitors* / therapeutic use
Pyrimidines / therapeutic use
Substances
Janus Kinase Inhibitors
Pyrimidines